Opportunity Information: Apply for RFA EB 23 005

Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) is a National Institutes of Health (NIH) funding opportunity that supports exploratory, early-stage research focused on the ethical questions that come up when bionic and robotic technologies are created and moved into real-world use. The central idea is that ethics is not an afterthought in this field; it is built into every step of the process. Projects are expected to examine bioethical issues that can arise across the full lifecycle of these technologies, including device design decisions, laboratory and preclinical work, first-in-human and later-stage testing (if applicable), and broader implementation in clinical care or community settings. Because this is an R21 mechanism, it is generally aimed at innovative, proof-of-concept work that can generate foundational evidence, frameworks, or methods that later efforts can build on. The listing notes that clinical trials are optional, meaning applicants can propose studies that do not involve clinical trials as well as projects that may include them, as long as the work fits the ethical research focus.

The scope is deliberately broad: it covers both bionic devices (such as prosthetics, neural interfaces, sensory restoration systems, or implantable assistive technologies) and robotic devices (including rehabilitation robotics, assistive robots, or other human-interactive robotic systems). The ethical research may address questions that emerge during development and translation, such as how researchers and developers should weigh benefits and risks, how informed consent should be handled when devices are complex or rapidly evolving, how to manage uncertainty about long-term effects, and how to ensure that user perspectives and lived experience meaningfully shape design and evaluation. It also naturally includes issues tied to autonomy, agency, identity, privacy and data governance (especially where sensors or neural data are involved), accountability when systems fail or behave unpredictably, fairness and access, appropriate participant selection, and responsible communication about capabilities and limitations to avoid hype or therapeutic misconception. The emphasis is not on building the devices themselves, but on producing rigorous research that clarifies ethical challenges and proposes practical, evidence-informed approaches to address them.

The opportunity is identified as RFA-EB-23-005 and falls under a discretionary grant category, with a funding activity category of health and CFDA number 93.286. The original closing date listed is 2025-01-22, and the opportunity was created on 2023-04-28. While the provided source text does not specify an award ceiling or expected number of awards, it clearly frames the program’s purpose: to stimulate bioethics research that keeps pace with fast-moving bionic and robotic innovation and helps guide responsible translation into practice.

Eligibility is broad and includes many types of U.S.-based applicants: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The NOFO also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions, as well as Indian/Native American tribal governments that are not federally recognized.

For international participation, the rules are specific: non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization. However, non-domestic components of U.S. organizations are eligible, and foreign components, as defined by the NIH Grants Policy Statement, are allowed. In practice, that means a U.S. applicant can include certain foreign collaborations or project components when justified and compliant with NIH policy, but a foreign institution cannot serve as the primary applicant.

Overall, this NOFO is aimed at building the ethical evidence base and practical guidance needed to develop and translate bionic and robotic devices responsibly. It supports projects that can meaningfully influence how these technologies are designed, tested, evaluated, and implemented, with careful attention to human subjects, users, communities, and the broader societal impact of increasingly intimate human-machine systems.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286.
  • This funding opportunity was created on 2023-04-28.
  • Applicants must submit their applications by 2025-01-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA EB 23 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the focus of this funding opportunity?

This opportunity supports exploratory, early-stage research on bioethical issues that arise during the development and real-world translation of bionic and robotic devices. The emphasis is on ethics as a core part of the technology lifecycle rather than something addressed after devices are already built or deployed.

What is the official name of the opportunity?

The opportunity is titled "Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)."

What agency is offering this grant?

The funding opportunity is offered by the National Institutes of Health (NIH).

What is the funding opportunity number (RFA)?

The opportunity is identified as RFA-EB-23-005.

What grant mechanism does this use, and what does that imply?

This is an R21 mechanism, which is generally intended for innovative, exploratory, proof-of-concept research. Projects are expected to generate foundational evidence, frameworks, or methods that later research can build on.

Are clinical trials required?

No. Clinical trials are optional. Applicants may propose projects without clinical trials, or propose work that includes them, as long as the project remains focused on bioethical research related to bionic and robotic device development and translation.

What kinds of technologies fall within the scope of this program?

The scope is broad and includes both bionic devices and robotic devices. Examples mentioned include prosthetics, neural interfaces, sensory restoration systems, implantable assistive technologies, rehabilitation robotics, assistive robots, and other human-interactive robotic systems.

What parts of the technology lifecycle can a project address?

Projects are expected to examine ethical issues that can arise across the full lifecycle, including device design decisions, laboratory and preclinical work, first-in-human and later-stage testing (if applicable), and broader implementation in clinical care or community settings.

Is this grant meant to fund building or engineering the devices?

The emphasis is not on building the devices themselves. The focus is on producing rigorous ethics research that clarifies ethical challenges and proposes practical, evidence-informed approaches to address them.

What kinds of bioethical questions does NIH expect projects to study?

The description highlights a range of topics, including how developers and researchers weigh benefits and risks; how informed consent should be handled when devices are complex or rapidly evolving; how to manage uncertainty about long-term effects; and how to ensure user perspectives and lived experience meaningfully shape design and evaluation.

What human-centered ethics issues are explicitly called out?

The opportunity points to issues involving autonomy, agency, identity, and ensuring that users and communities have meaningful input into design and evaluation.

Does the scope include privacy and data governance concerns?

Yes. Privacy and data governance are included, especially in contexts where sensors or neural data may be involved.

Does the program address responsibility and accountability when systems fail?

Yes. The description notes accountability concerns, including situations where systems fail or behave unpredictably.

Are fairness and access considered within scope?

Yes. Fairness and access are explicitly included among the ethical issues that may be addressed.

Does the opportunity mention responsible communication about device capabilities?

Yes. It emphasizes responsible communication about capabilities and limitations to avoid hype or therapeutic misconception.

What is the CFDA number and general funding category?

The listing notes CFDA number 93.286 and indicates the funding activity category is health.

When was this opportunity created?

The opportunity was created on 2023-04-28.

What is the closing date listed for this opportunity?

The original closing date listed is 2025-01-22.

Does the provided information state an award ceiling or number of awards?

No. The provided source text does not specify an award ceiling or the expected number of awards.

Who is eligible to apply within the United States?

Eligibility is broad and includes many U.S.-based applicant types, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status, other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities.

Are particular institution types explicitly highlighted as eligible?

Yes. The NOFO explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and Indian/Native American tribal governments that are not federally recognized.

Can a foreign (non-U.S.) organization apply as the main applicant?

No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization.

Can a U.S. applicant include foreign collaborations or components?

Yes. Non-domestic components of U.S. organizations are eligible, and foreign components (as defined by the NIH Grants Policy Statement) are allowed. In practical terms, a U.S. applicant may include certain foreign project components or collaborations when justified and compliant with NIH policy, but a foreign institution cannot serve as the primary applicant.

What is the overarching purpose of this NOFO?

The program aims to stimulate bioethics research that keeps pace with fast-moving bionic and robotic innovation and helps guide responsible translation into practice, building an ethical evidence base and practical guidance for how these technologies are designed, tested, evaluated, and implemented.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: 1890 Institution Teaching, Research, and Extension Capacity Building Grants Program

Previous opportunity: BJA FY 23 Upholding the Rule of Law and Preventing Wrongful Convictions Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA EB 23 005

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA EB 23 005) also looked into and applied for these:

Funding Opportunity
NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed) Apply for PAR 23 175

Funding Number: PAR 23 175
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
APS - Strengthening Health Services, Demand, and Systems in Benin Apply for 72068023APS00001

Funding Number: 72068023APS00001
Agency: Benin USAID-Cotonou
Category: Health
Funding Amount: $65,000,000
NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) Apply for RFA NS 24 020

Funding Number: RFA NS 24 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 021

Funding Number: RFA RM 23 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 020

Funding Number: RFA RM 23 020
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
AHRQ Health Services Research Dissertation Program (R36) Apply for PA 23 196

Funding Number: PA 23 196
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional) Apply for RFA NS 24 011

Funding Number: RFA NS 24 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,750,000
Sex Differences in Radiation Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 024

Funding Number: RFA AI 23 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Apply for RFA OD 23 016

Funding Number: RFA OD 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) Apply for PAR 23 143

Funding Number: PAR 23 143
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) Apply for PAR 23 142

Funding Number: PAR 23 142
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed) Apply for RFA AG 24 017

Funding Number: RFA AG 24 017
Agency: National Institutes of Health
Category: Health
Funding Amount: $9,000,000
Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) Apply for PAR 23 174

Funding Number: PAR 23 174
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) Apply for PAR 23 177

Funding Number: PAR 23 177
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
HIV Prevention and Alcohol (R01 Clinical Trials Optional) Apply for PAS 23 173

Funding Number: PAS 23 173
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Prevention and Alcohol (R34 Clinical Trials Optional) Apply for PAS 23 172

Funding Number: PAS 23 172
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 23 185

Funding Number: PAR 23 185
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 23 186

Funding Number: PAR 23 186
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 187

Funding Number: PAR 23 187
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 24 010

Funding Number: RFA NS 24 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA EB 23 005", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: